Hepanostika® HBsAg Ultra - New "ultra"-sensitive test for Hepatitis B infection from bioMérieux
07-Jul-2005
Hepanostika HBsAg Ultra enables detection of all known subtypes and clinically relevant variants of HBsAg using a convenient test procedure. The ability of the test to detect mutant antigen enables accurate patient diagnosis and ensures reliable screening of blood-transfusion products. Hepanostika HBsAg Ultra is a CE-marked in vitro diagnostic product and will initially be commercialized in Europe and the Middle-East.
Most read news
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.